New drug aims to stop lung cancer relapse after Chemo-Radiation

NCT ID NCT06117774

Disease control Sponsor: Amgen Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This phase 3 study tests whether tarlatamab, an experimental drug, can delay cancer progression or improve survival in people with limited-stage small-cell lung cancer who have finished chemoradiation without their cancer getting worse. About 404 participants will receive either tarlatamab or a placebo by IV infusion. The goal is to see if the drug helps keep the cancer under control longer than standard monitoring alone.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance: tarlatamab (a drug given by IV infusion)
What this could lead to: If successful, tarlatamab could offer a new maintenance therapy to keep limited-stage small-cell lung cancer from returning or progressing after initial treatment.
What could go wrong: This is a phase 3 trial, but the drug is still experimental. It may not improve survival or delay progression compared to placebo, and side effects from the immune-targeting drug could be significant.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

404 people

The number who actually took part.

Started

Feb 2024

Expected to finish

Apr 2030

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: -Participants are eligible to be included in the study only if all of the following criteria apply: * Participant has provided informed consent prior to initiation of any study specific activities/procedures. * Age ≥ 18 years (or ≥ legal age within the country if it is older than 18 years). * Histologically or cytologically confirmed small-cell lung cancer (SCLC). * Diagnosed and treated for LS-SCLC with concurrent chemotherapy and radiotherapy. * Has completed chemoradiotherapy without progression per RECIST 1.1 (ie, achieved complete response \[CR\], partial response \[PR\], or stable disease \[SD\]). * Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) of 0 or 1. * Minimum life expectancy of 12 weeks. * Adequate organ function. * Toxicities attributed to concurrent chemoradiotherapy resolved to grade ≤ 1, unless otherwise specified. Excluding alopecia or fatigue. Exclusion Criteria: -Participants are excluded from the study if any of the following criteria apply: Disease Related * Extensive-stage SCLC (ES-SCLC). * Any previous diagnosis of transformed non-small-cell lung cancer (NSCLC), epidermal growth factor receptor (EGFR) activating mutation positive NSCLC that has transformed to SCLC, or mixed SCLC NSCLC histology. * Evidence of interstitial lung disease or active, non-infectious pneumonitis. Other Medical Conditions * History of other malignancy within the past 2 years, with certain exceptions. * History of solid organ transplantation. * Myocardial infarction and/or symptomatic congestive heart failure (New York Heart Association \> class II) within 6 months prior to first dose of study treatment. * History of arterial thrombosis (eg, stroke or transient ischemic attack) within 6 months prior to first dose of study treatment. * Exclusion of human immunodeficiency virus (HIV) or active hepatitis infection based on criteria per protocol. * Participant with symptoms and/or clinical signs and/or radiographic signs that indicate an acute and/or uncontrolled active systemic infection within 7 days prior to the first dose of study treatment. Prior/Concomitant Therapy * Received sequential chemotherapy and thoracic radiotherapy (no overlap of thoracic radiotherapy with chemotherapy) during chemoradiation. * Prior therapy with any selective inhibitor of the delta-like ligand 3 (DLL3) pathway. * Prior history of severe or life-threatening events from any immune-mediated therapy. * Receiving another anti-cancer therapy. Adjuvant hormonal therapy for resected breast cancer is permitted. * Receiving systemic corticosteroid therapy or any other form of immunosuppressive therapy within 7 days prior to enrollment. * Major surgical procedures within 28 days prior to first dose of study treatment. * Treatment with live virus, including live-attenuated vaccination, within 14 days prior to the first dose of study treatment. Inactive vaccines and live viral non-replicating vaccines within 3 days prior to first dose of study treatment. Prior/Concurrent Clinical Study Experience • Treatment in an alternative investigational trial within 28 days prior to enrollment. Other Exclusions * Female participants of childbearing potential unwilling to use protocol specified method of contraception during treatment and for an additional 60 days after the last dose of study treatment. * Female participants who are breastfeeding or who plan to breastfeed while on study through 60 days after the last dose of study treatment. * Female participants planning to become pregnant or donate eggs while on study through 60 days after the last dose of study treatment. * Female participants of childbearing potential with a positive pregnancy test assessed at screening by a highly sensitive serum pregnancy test. * Male participants with a female partner of childbearing potential who are unwilling to practice sexual abstinence (refrain from heterosexual intercourse) or use contraception during treatment and for an additional 60 days after the last dose of study treatment. * Male participants with a pregnant partner who are unwilling to practice abstinence or use a condom during treatment and for an additional 60 days after the last dose of study treatment. * Male participants unwilling to abstain from donating sperm during treatment and for an additional 60 days after the last dose of study treatment. * Participant has known sensitivity to any of the products or components to be administered during dosing. * Participant likely to not be available to complete all protocol-required study visits or procedures, and/or to comply with all required study procedures to the best of the participant and investigator's knowledge. * History or evidence of any other clinically significant disorder, condition, or disease (with the exception of those outlined above) that, in the opinion of the investigator or Amgen physician, if consulted, would pose a risk to participant safety or interfere with the study evaluation, procedures or completion.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Limited stage small cell lung cancer Small cell lung cancer

Contacts and locations

Locations

Agios Savvas Anticancer Hospital

Athens, 11522, Greece
Ankara Bilkent Sehir Hastanesi

Ankara, 06800, Turkey (Türkiye)
Ankara Etlik Sehir Hastanesi

Ankara, 06200, Turkey (Türkiye)
Asan Medical Center

Seoul, 05505, South Korea
Azienda Ospedaliera Universitaria San Luigi Gonzaga

Orbassano, 10043, Italy
Azienda Ospedaliera di Perugia Ospedale Santa Maria della Misericordia

Perugia, 06156, Italy
Azienda Ospedaliero Universitaria Pisana

Pisa, 56124, Italy
Azienda Unita Sanitaria Locale di Reggio Emilia Arcispedale Santa Maria Nuova

Reggio Emilia, 42123, Italy
Bagcilar Medipol Mega Universite Hastanesi

Istanbul, 34214, Turkey (Türkiye)
Beijing Cancer Hospital

Beijing, Beijing Municipality, 100142, China
Boca Raton Clinical Research Global South Florida

Plantation, Florida, 33322, United States
Cancer Hospital of Shandong First Medical University

Jinan, Shandong, 250117, China
Centre Hospitalier Régional Universitaire de Lille - Institut Coeur Poumon

Lille, 59037, France
Centre Hospitalier Universitaire Nord

Marseille, 13915, France
Centre Hospitalier Universitaire de Nice - Hopital Pasteur

Nice, 06002, France
Centro Catarinense de Pesquisa LTDA

Blumenau, Santa Catarina, 89015-200, Brazil
Centro Oncologico Personalizado

Cuauhtémoc, Mexico City, 06760, Mexico
Centro de Tratamiento e Investigación sobre Cancer Luis Carlos Sarmiento Angulo Ctic

Bogota, Cundinamarca, 0129, Colombia
Centro de pesquisa em oncologia Hospital Ana Nery

Santa Cruz do Sul, Rio Grande do Sul, 96835-090, Brazil
Centro di Riferimento Oncologico di Aviano

Aviano PN, 33081, Italy
Centrul de Oncologie Sf Nectarie SRL

Craiova, 200542, Romania
Centrum Pulmonologii i Torakochirurgii w Bystrej

Bystra, 43-360, Poland
Cepho

Santo André, São Paulo, 09060-650, Brazil
Cha Bundang Medical Center, Cha University

Seongnam-si, Gyeonggi-do, 13496, South Korea
Chongqing University Cancer Hospital

Chongqing, Chongqing Municipality, 400030, China
Christie Hospital

Manchester, M20 4BX, United Kingdom
Chungbuk National University Hospital

Cheongju Chungbuk, 28644, South Korea
Cipo - Centro Integrado de Pesquisa em Oncologia

Porto Alegre, Rio Grande do Sul, 91350-200, Brazil
Clinica Universidad de Navarra

Pamplona, Navarre, 31008, Spain
Clinica Viedma

Viedma, Río Negro Province, R8500ACE, Argentina
Complex Oncology Center Plovdiv EOOD

Plovdiv, 4004, Bulgaria
Complex Oncology Center Shumen EOOD

Shumen, 9700, Bulgaria
Dokkyo Medical University Hospital

Shimotsuga-gun, Tochigi, 321-0293, Japan
Dr Suat Seren Gogus Hastaliklari ve Cerrahisi Egitim ve Arastirma Hastanesi

Izmir, 35110, Turkey (Türkiye)
European Interbalkan Medical Center

Thessaloniki, 57001, Greece
Fiona Stanley Hospital

Murdoch, Western Australia, 6150, Australia
FirstHealth Cancer Center

Pinehurst, North Carolina, 28374, United States
Flinders Medical Centre

Bedford Park, South Australia, 5042, Australia
Fondazione IRCCS Istituto Nazionale dei Tumori

Milan, 20133, Italy
Fudan University Shanghai Cancer Center

Shanghai, Shanghai Municipality, 200032, China
Fujian Cancer Hospital

Fuzhou, Fujian, 350014, China
Fundacao Amaral Carvalho

Jaú, São Paulo, 17210-120, Brazil
Fundacao pio xII Barretos

Barretos, São Paulo, 14784-400, Brazil
Fundacion Respirar

Ciudad Autonoma de Buenos Aires, Buenos Aires, C1426ABP, Argentina
Fundacion cardiovascular de Colombia

Bucaramanga, Santander Department, 681017, Colombia
Gachon University Gil Medical Center

Incheon, 405-760, South Korea
Gazi Universitesi Saglik Arastirma ve Uygulama Merkezi Gazi Hastanesi

Ankara, 06560, Turkey (Türkiye)
Goztepe Prof Dr Suleyman Yalcin Sehir Hastanesi

Istanbul, 34722, Turkey (Türkiye)
Guys Hospital

London, SE1 9RT, United Kingdom
Gyeongsang National University Hospital

Jinju, 52727, South Korea
Henan Cancer Hospital

Zhengzhou, Henan, 450003, China
Henry Dunant Hospital Center

Athens, 11526, Greece
Hopital Bichat Claude Bernard

Paris, 75018, France
Hopital Nord Ouest Villefranche sur Saone

Villefranche-sur-Saône, 69400, France
Hospital Aleman Buenos Aires

CABA, Distrito Federal, C1118AAT, Argentina
Hospital Clinic i Provincial de Barcelona

Barcelona, Catalonia, 08036, Spain
Hospital Clinico Universitario Lozano Blesa

Zaragoza, Aragon, 50009, Spain
Hospital Clinico Universitario de Santiago

Santiago de Compostela, Galicia, 15706, Spain
Hospital Cuf porto

Porto, 4100-180, Portugal
Hospital General Universitario Gregorio Maranon

Madrid, 28009, Spain
Hospital Italiano de La Plata

La Plata, Buenos Aires, 1900, Argentina
Hospital Regional Universitario de Malaga

Málaga, Andalusia, 29011, Spain
Hospital Santa Rita

Vitória, Espírito Santo, 29043-260, Brazil
Hospital Sao Lucas da Pontificia Universidade Catolica do Rio Grande do Sul

Porto Alegre, Rio Grande do Sul, 90610-000, Brazil
Hospital Universitari Vall d Hebron

Barcelona, Catalonia, 08035, Spain
Hospital Universitario 12 de Octubre

Madrid, 28041, Spain
Hospital Universitario Austral

Pilar, Buenos Aires, B1629ODT, Argentina
Hospital Universitario Insular de Gran Canaria

Las Palmas de Gran Canaria, Canary Islands, 35016, Spain
Hospital Universitario Puerta de Hierro Majadahonda

Majadahonda, Madrid, 28222, Spain
Hospital Universitario Virgen del Rocio

Seville, Andalusia, 41013, Spain
Hospital da Luz, SA

Lisbon, 1500-650, Portugal
Hospital de Clinicas de Porto Alegre

Porto Alegre, Rio Grande do Sul, 90035-003, Brazil
Hospital de la Santa Creu i Sant Pau

Barcelona, Catalonia, 08041, Spain
Hospital del Mar

Barcelona, Catalonia, 08003, Spain
Hubei Cancer Hospital

Wuhan, Hubei, 430070, China
Hunan Cancer Hospital

Changsha, Hunan, 410013, China
IRCCS Istituto Clinico Humanitas

Rozzano MI, 20089, Italy
IRCCS Istituto Oncologico Europeo

Milan, 20141, Italy
Icon - Mount Alvernia

Singapore, 217562, Singapore
Institut Catala d Oncologia Badalona Hospital Universitari Germans Trias i Pujol

Badalona, Catalonia, 08916, Spain
Institut Jules Bordet

Brussels, B-1070, Belgium
Instituto Argentino de Diagnóstico y Tratamiento

Buenos Aires, C1122AAL, Argentina
Instituto Cancer Sao Paulo Icesp

São Paulo, 01246-000, Brazil
Instituto Dor de Pesquisa e Ensino

Rio de Janeiro, 22793-080, Brazil
Instituto Medico de Alta Tecnologia sas - Imat sas

Montería, Departamento de Córdoba, Colombia
Instituto Nacional de Cancerologia

Bogota, Cundinamarca, 111711, Colombia
Instituto Oncologico de Cordoba Ionc Fundacion Richardet Longo

Córdoba, Córdoba Province, 5003, Argentina
Instituto Valenciano de Oncologia

Valencia, Valencia, 46009, Spain
Institutul Oncologic Prof Dr Ion Chiricuta Cluj-Napoca

Cluj-Napoca, 400015, Romania
Institutul Oncologic, Prof Dr Alexandru Trestioreanu

Bucharest, 022328, Romania
Institutul Regional de Oncologie Iasi

Iași, 700483, Romania
Istituto Oncologico Veneto IRCCS

Padova, 35128, Italy
Izmir Ekonomi Universitesi Medical Point Hastanesi

Izmir, 35575, Turkey (Türkiye)
Jiangxi Cancer hospital

Nanchang, Jiangxi, 330029, China
Juntendo University Hospital

Bunkyo-ku, Tokyo, 113-8431, Japan
Kanagawa Prefectural Hospital Organization Kanagawa Cancer Center

Yokohama, Kanagawa, 241-8515, Japan
Kansai Medical University Hospital

Hirakata-shi, Osaka, 573-1191, Japan
Kantonsspital Baden

Baden, 5404, Switzerland
Kaohsiung Medical University Chung-Ho Memorial Hospital

Kaohsiung City, 80756, Taiwan
Kindai University Hospital

Osakasayama-shi, Osaka, 589-8511, Japan
Kocaeli Universitesi Tip Fakultesi Hastanesi

Kocaeli, 41380, Turkey (Türkiye)
Kurume University Hospital

Kurume-shi, Fukuoka, 830-0011, Japan
Lehigh Valley Health Network

Allentown, Pennsylvania, 18103, United States
Liga Norte-Riograndense Contra O Cancer

Natal, Rio Grande do Norte, 59075-740, Brazil
Liga Paranaense do Combate ao Cancer - Hospital Erasto Gaertner

Curitba, Paraná, 81520-060, Brazil
Londrina Cancer Hospital

Londrina, Paraná, 86015-520, Brazil
Marmara Universitesi Tip Fakultesi Hastanesi

Istanbul, 34890, Turkey (Türkiye)
Medical Park Seyhan Hastanesi

Mersin, 33200, Turkey (Türkiye)
Medizinische Universitaet Graz

Graz, 8036, Austria
Memorial Ankara Hastanesi

Ankara, 06520, Turkey (Türkiye)
Mengchao Hepatobiliary Hospital of Fujian Medical University

Fuzhou, Fujian, 350025, China
Metropolitan General

Athens, 15562, Greece
Metropolitan Hospital

Athens, 18547, Greece
Military Medical Academy Multiprofile Hospital for Active Treatment - Sofia

Sofia, 1606, Bulgaria
Monash Medical Centre

Clayton, Victoria, 3168, Australia
Montefiore Einstein Center for Cancer Care

The Bronx, New York, 10461, United States
Morristown Medical Center

Morristown, New Jersey, 07960, United States
Multiprofile Hospital for Active Treatment - Uni Hospital OOD

Panagyurishte, 4500, Bulgaria
Multiprofile Hospital for Active Treatment Serdikamed EOOD

Sofia, 1632, Bulgaria
Narodowy Instytut Onkologii im Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy

Warsaw, 02-781, Poland
National Cancer Center

Goyang-si Gyeonggi-do, 10408, South Korea
National Cancer Center Hospital

Chuo-ku, Tokyo, 104-0045, Japan
National Cancer Center Hospital East

Kashiwa-shi, Chiba, 277-8577, Japan
National Cancer Centre Singapore

Singapore, 168583, Singapore
National Hospital Organization Hokkaido Cancer Center

Sapporo, Hokkaido, 003-0804, Japan
National Hospital Organization Nagoya Medical Center

Nagoya, Aichi-ken, 460-0001, Japan
National Hospital Organization Shikoku Cancer Center

Matsuyama, Ehime, 791-0280, Japan
National Taiwan University Hospital

Taipei, 10002, Taiwan
New York University Grossman School of Medicine and New York University Langone Hospitals

New York, New York, 10016, United States
Niigata Cancer Center Hospital

Niigata, Niigata, 951-8566, Japan
Ningbo Medical Center Lihuili Hospital

Ningbo, Zhejiang, 315016, China
Norrlands Universitetssjukhus

Umeå, 901 85, Sweden
Northern Jiangsu Peoples hospital

Yangzhou, Jiangsu, 225009, China
Okayama University Hospital

Okayama, Okayama-ken, 700-8558, Japan
Oncare

Mexico City, Mexico City, 03810, Mexico
Oncocenter Clinica Integral Internacional de Oncologia

Puebla City, 72530, Mexico
Oncoclinicas Onco Vida Distrito Federal

Brasília, Federal District, 70200-730, Brazil
Oncologos del Occidente SAS

Pereira, Risaralda Department, 660001, Colombia
Ondokuz Mayis Universitesi Tip Fakultesi Hastanesi

Samsun, 55200, Turkey (Türkiye)
Osaka International Cancer Institute

Osaka, Osaka, 541-8567, Japan
Ospedale Regionale di Bellinzona e Vali

Mendrisio, 6850, Switzerland
Ospedale San Giuseppe Moscati

Statte, 74010, Italy
Our Lady of the Lake Cancer Institute

Baton Rouge, Louisiana, 70808, United States
Perlmutter Cancer Center at New York University Langone Hospital - Long Island

New York, New York, 10016, United States
Phylasis Clinicas Research Toluca

Toluca, 50090, Mexico
Port Macquarie Base Hospital

Port Macquarie, New South Wales, 2444, Australia
Prince of Wales Hospital, Chinese University of Hong Kong

Shatin, New Territories, Hong Kong
Qingdao Municipal Hospital

Qingdao, Shandong, 266000, China
Queen Mary Hospital, The University of Hong Kong

Hong Kong, Hong Kong
Renmin Hospital of Wuhan University

Wuhan, Hubei, 430060, China
Renovatio Clinical

The Woodlands, Texas, 77380, United States
SC Oncomed SRL

Timișoara, 300239, Romania
Sahlgrenska Universitetssjukhuset

Gothenburg, 413 45, Sweden
Saint Luke Hospital

Thessaloniki, 55236, Greece
Saitama Cancer Center

Kitaadachi-gun, Saitama, 362-0806, Japan
Saitama Medical University International Medical Center

Hidaka-Shi, Saitama, 350-1298, Japan
Samsung Medical Center

Seoul, 06351, South Korea
Sanatorio 9 de Julio Cice 9 de Julio

San Miguel de Tucumán, Tucumán Province, 4000, Argentina
Sendai Kousei Hospital

Sendai, Miyagi, 981-0914, Japan
Seoul National University Bundang Hospital

Seongnam-si, Gyeonggi-do, 13620, South Korea
Seoul National University Hospital

Seoul, 110-744, South Korea
Severance Hospital Yonsei University Health System

Seoul, 03722, South Korea
Shanxi Bethune Hospital

Taiyuan, Shanxi, 030032, China
Shanxi Provincial Cancer Hospital

Taiyuan, Shanxi, 030009, China
Shizuoka Cancer Center

Sunto-gun, Shizuoka, 411-8777, Japan
Sotiria General Hospital

Athens, 11527, Greece
Spitalul Clinic de Urgenta Prof Dr Agrippa Ionescu

Balotesti, Ilfov, 077015, Romania
Spitalul Municipal Ploiesti

Ploieşti, 100337, Romania
Spokenword Clinical Trials

Easton, Pennsylvania, 18045, United States
Sun Yat-Sen University Cancer Center

Guangzhou, Guangdong, 510060, China
Szpital Specjalistyczny w Prabutach Spolka z Ograniczoną Odpowiedzialnoscia

Prabuty, 82-550, Poland
Taipei Veterans General Hospital

Taipei, 11217, Taiwan
The Cancer Institute Hospital of Japanese Foundation for Cancer Research

Koto-ku, Tokyo, 135-8550, Japan
The First Affiliated Hospital of Xinjiang Medical University

Ürümqi, Xinjiang, 830011, China
The First Bethune Hospital of Jilin University

Changchun, Jilin, 130021, China
The Second Affiliated Hospital of Zhejiang University School of Medicine

Hangzhou, Zhejiang, 310003, China
Tianjin Cancer Hospital

Tianjin, Tianjin Municipality, 300060, China
Tongji Hospital Tongji Medical College Huazhong University of Science and Technology

Wuhan, Hubei, 430030, China
US Oncology Research Investigational Products Center

The Woodlands, Texas, 77380, United States
Unidade Local de Saude de Braga, EPE

Braga, 4710-243, Portugal
Universitaetsklinikum Allgemeines Krankenhaus Wien

Vienna, 1090, Austria
Universitaetsklinikum Essen

Essen, 45147, Germany
Universitaetsklinikum Wuerzburg

Würzburg, 97078, Germany
Universitaetsmedizin Goettingen

Göttingen, 37075, Germany
Universitaetsspital Basel

Basel, 4052, Switzerland
Universitair Ziekenhuis Gent

Ghent, 9000, Belgium
University General Hospital Attikon General Hospital Of West Attica H Agia Varvara

Athens, 12462, Greece
University Multiprofile Hospital for Active Treatment Sofiamed OOD

Sofia, 1113, Bulgaria
University Multiprofile Hospital for Active Treatment Tsaritsa Yoanna - ISUL EAD

Sofia, 1527, Bulgaria
University of California Los Angeles

Santa Monica, California, 90404, United States
University of Louisville James Graham Brown Cancer Center

Louisville, Kentucky, 40202, United States
University of Virginia Health System

Charlottesville, Virginia, 22908, United States
Uniwersytecki Szpital Kliniczny Nr 4 w Lublinie

Lublin, 20-090, Poland
Uniwersytecki Szpital Kliniczny w Bialymstoku

Bialystok, 15-540, Poland
Uniwersyteckie Centrum Kliniczne

Gdansk, 80-214, Poland
Valkyrie Clinical Trials

Los Angeles, California, 90067, United States
Virginia Cancer Specialists, PC

Fairfax, Virginia, 22031, United States
Wakayama Medical University Hospital

Wakayama, 641-8509, Japan
West Virginia University Health Sciences Center

Morgantown, West Virginia, 26506, United States
Westmead Hospital

Westmead, New South Wales, 2145, Australia
Wielkopolskie Centrum Pulmonologii i Torakochirurgii imienia Eugenii i Janusza Zeylandow

Poznan, 60-569, Poland
Wojewodzki Szpital im Sw Ojca Pio w Przemyslu

Przemyśl, 37-700, Poland
Yale New Haven Hospital

New Haven, Connecticut, 06510, United States
Zhejiang Taizhou Hospital

Taizhou, Zhejiang, 317099, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.